By G HossainPosted on July 28, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Oak Hill Bio is developing the antisense therapy rugonersen, which it licensed from Roche in 2025, for Angelman syndrome. Oak Hill takes SPAC track to Nasdaq with Roche asset in tow Post navigation As pharma descends on China for deals, BIOSECURE Act raises intellectual property riskApnimed eyes up to $160M IPO to prep for sleep apnea drug launch
